Latest

Oct 24, 2017
Pharmaceutical Executive
Navigating Data Privacy and Security Considerations in the Life Sciences Industry
Oct 19, 2017
Selecta Biosciences CEO Dr. Werner Cautreels talks about the company's innovative technology and how his entrepreneurial experiences in big pharma prepared him for the challenge of a new startup.
Oct 09, 2017
Pharmaceutical Executive
What is the true potential of real-world evidence studies and what are the right questions to ask in determining product performance in the marketplace?
Oct 06, 2017
TESARO president and COO Mary Lynne Hedley talks about responsible drug development and commercialization, and the practical dimension of putting patients first.
Oct 03, 2017
With the NASH pipeline filling up fast, Mariel Metcalfe looks at what pharma companies need to do to ensure their products do not end up as also-rans in this dynamic new market segment.
Oct 03, 2017
Jayachandra Reddy and Rishit Thakkar discuss the challenges facing early entrants in the Non-alcoholic Steatohepatitis market.
Sep 22, 2017
Healthcare companies are overwhelming physicians and hospitals with brand messaging overlap. Let’s use data science to fix that, says Kevin Troyanos.
Sep 21, 2017
Pharmaceutical Executive
Despite delay in enforcement of Drug Supply Chain Security Act's new serialization requirement, getting compliant now is key.
Sep 15, 2017
A review of a recent FSP in which the CRO partner assumed clinical monitoring and site support responsibility for more than 50 ongoing trials.
Sep 04, 2017
Lisa Kerber outlines how the pharma industry can take advantage of combining new clinical data sources such as diagnostics, or lab data, with AI to deliver on the promise of improving outcomes.
native1_300x100
lorem ipsum